Invesco Ltd. Acquires 13,224 Shares of Acadia Healthcare Company, Inc. $ACHC

Key Points

• Invesco Ltd. increased its stake in Acadia Healthcare by 5.7% during the first quarter, bringing its total holdings to approximately $7.38 million for 243,311 shares.
• Acadia Healthcare reported quarterly earnings of $0.83 per share, surpassing analyst expectations, and saw a revenue increase of 9.2% compared to the previous year.
• The average analyst rating for Acadia Healthcare is currently a "Moderate Buy", with a target price of $40.77 based on recent ratings from nine analysts.

Invesco Ltd. increased its stake in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) by 5.7% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 243,311 shares of the company's stock after buying an additional 13,224 shares during the quarter. Invesco Ltd. owned 0.26% of Acadia Healthcare worth $7,377,000 at the end of the most recent quarter.

Other institutional investors have also bought and sold shares of the company. UMB Bank n.a. grew its holdings in Acadia Healthcare by 149.5% during the first quarter. UMB Bank n.a. now owns 1,260 shares of the company's stock worth $38,000 after buying an additional 755 shares in the last quarter. State of Wyoming purchased a new position in Acadia Healthcare in the fourth quarter worth $56,000. Covestor Ltd boosted its position in Acadia Healthcare by 56.0% in the first quarter. Covestor Ltd now owns 2,262 shares of the company's stock worth $69,000 after purchasing an additional 812 shares during the last quarter. Aquatic Capital Management LLC purchased a new position in Acadia Healthcare in the fourth quarter worth $97,000. Finally, GAMMA Investing LLC boosted its position in Acadia Healthcare by 143.8% in the first quarter. GAMMA Investing LLC now owns 5,812 shares of the company's stock worth $176,000 after purchasing an additional 3,428 shares during the last quarter.

Acadia Healthcare Stock Performance

Shares of NASDAQ:ACHC traded up $0.34 during midday trading on Friday, reaching $22.96. 2,743,238 shares of the company traded hands, compared to its average volume of 2,671,607. The company has a quick ratio of 1.32, a current ratio of 1.32 and a debt-to-equity ratio of 0.73. Acadia Healthcare Company, Inc. has a 12 month low of $17.13 and a 12 month high of $82.40. The firm has a market capitalization of $2.12 billion, a price-to-earnings ratio of 15.21, a price-to-earnings-growth ratio of 4.52 and a beta of 0.89. The firm's fifty day moving average price is $22.01 and its two-hundred day moving average price is $25.32.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last released its quarterly earnings data on Tuesday, August 5th. The company reported $0.83 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.71 by $0.12. Acadia Healthcare had a return on equity of 8.34% and a net margin of 4.31%.The company had revenue of $869.23 million for the quarter, compared to analyst estimates of $839.59 million. During the same period in the previous year, the company posted $0.91 EPS. The firm's revenue for the quarter was up 9.2% compared to the same quarter last year. Acadia Healthcare has set its FY 2025 guidance at 2.450-2.65 EPS. On average, equities analysts expect that Acadia Healthcare Company, Inc. will post 3.38 earnings per share for the current year.

Analysts Set New Price Targets

ACHC has been the topic of several research analyst reports. Mizuho cut their price objective on Acadia Healthcare from $32.00 to $22.00 and set a "neutral" rating on the stock in a research report on Wednesday, August 13th. Stephens raised Acadia Healthcare to a "hold" rating in a research report on Monday, June 2nd. Barclays cut their price objective on Acadia Healthcare from $28.00 to $20.00 and set an "equal weight" rating on the stock in a research report on Thursday, August 7th. Royal Bank Of Canada cut their price objective on Acadia Healthcare from $43.00 to $28.00 and set an "outperform" rating on the stock in a research report on Wednesday, August 13th. Finally, UBS Group cut their price objective on Acadia Healthcare from $45.00 to $31.00 and set a "buy" rating on the stock in a research report on Thursday, August 7th. Nine equities research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $40.77.

Acadia Healthcare Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.